Both in Pharmaceuticals
Axsome Therapeutics vs Arrowhead Research
Over the past year AXSM returned +58.3% and ARWR returned +96.1%; their daily moves had a correlation of 0.27.
AXSM +58.3% ARWR +96.1%Growth of $1, one year, split-adjusted
| Metric | AXSM | ARWR |
|---|---|---|
| Price | $186.14 | $66.25 |
| Market cap | $9.75B | $9.36B |
| Today | −4.00% | +1.21% |
| 1 month | −6.5% | −22.0% |
| 6 months | +16.0% | +14.9% |
| Year to date | +1.9% | −0.2% |
| 1 year | +59.4% | +102.0% |
| Revenue growth (YoY) | +45.5% | +171.0% |
| Gross margin | 93.8% | 100.0% |
| Net margin | −23.5% | −258.2% |
| P/E (TTM) | — | — |
| Price / sales | 12.6× | 14.0× |
| Net cash | $122.9M | $737.9M |
| Dividend yield | — | — |
| Volatility (60d) | 42.3% | 62.0% |
| Short % of float | 7.8% | 6.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).